Status:
UNKNOWN
Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Epilepsy
Eligibility:
All Genders
18-90 years
Brief Summary
The investigators will check the serum of epilepsy patients for antibodies against glutamate receptors and double stranded DNA. They will characterise the patients (by the kind of epilepsy, autoimmune...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 120 epilepsy patients from the epilepsy clinic and Emergency Room (ER)
- Controls: 100 patients with other neurological diseases and no epilepsy; and 30 healthy volunteers.
Exclusion
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00317668
Start Date
November 1 2006
Last Update
May 1 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Ein-Kerem Medical Center
Jerusalem, Israel